Please ensure Javascript is enabled for purposes of website accessibility

Anthem Says COVID-19 Not a Major Factor in Its Financials... Yet

By Cory Renauer - Apr 29, 2020 at 5:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

But the giant health insurer recognizes that there could be trouble ahead.

On Wednesday, one of America's largest health insurers, Anthem (ANTM 2.71%) reported its results from the first three months of 2020. Thus far, it said, the COVID-19 pandemic hasn't affected the company's operating performance. However, management withdrew most of the details from the 2020 guidance it provided just a few months ago.  

Thinking ahead 

In January, Anthem forecast that its benefit ratio would drop about 1% compared to last year, to 85.8%, while operating earnings were expected to rise 23.3% to $7.4 billion. Due to the enormous level of uncertainty introduced by the coronavirus pandemic, the insurer has withdrawn these numbers and nearly all the other detailed predictions from its 2020 guidance.

Surgical mask close up

Image source: Getty Images.

The company said it would provide more details once visibility improves, but for now, the only figure it was ready to reaffirm was its forecast for the bottom line. Adjusted earnings are expected to rise at least 14.7% this year to $22.30 per share.

Unprecedented uncertainty

It's hard to tell if asking nearly all associates to work from home will affect earnings, but Anthem will record significant expenses associated with COVID-19 diagnostic tests and other services offered to members without any co-pays to offset them. In addition, Anthem has also waived cost-sharing for telehealth services and phone visits. 

During the first quarter, Anthem spent around $529 million repurchasing about 0.7% of its outstanding shares. Anthem had plans to spend another $3.3 billion on shares of its own stock, but buybacks will have to take a backseat to maintaining liquidity while the health insurer heads into uncharted economic territory.  

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Anthem, Inc. Stock Quote
Anthem, Inc.
ANTM
$482.58 (2.71%) $12.71

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
311%
 
S&P 500 Returns
110%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.